Neisseria gonorrhoeae is an important human pathogen. Each year in the United States, several million diagnostic tests are performed for gonococcal infection. The diagnosis in symptomatic men is most often based on a Gram-stained smear of urethral discharge, but the Gram stain is not a particularly sensitive or specific test for diagnosis of asymptomatic carriers or infection of the lower genital tract of women (4). The recommended procedure for diagnosing the infection in women involves culture of a cervical swab specimen on Thayer-Martin (TM) or similar media. Cultural procedures are recognized to have sensitivity problems, with the likelihood that only 80 to 90% of infections are accurately diagnosed by this method. In addition, the procedure is relatively costly and has an approximately 48-h turnaround time.
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Availability of a fairly rapid chemical-based assay or enzyme immunoassay (EIA) for detection of Neisseria gonorrhoeae would provide an alternative to culture and aid in efforts to control gonorrhea. Gonozyme (Abbott Laboratories) is an alternate method for the detection of gonorrhea and is commercially available. The system is based on solidphase immunoassay for detection of gonococcal antigen in swabs collected from the urethra or cervix. Herein we would like to present an evaluation of this method for diagnosis of gonorrhea in patients attending two sexually transmitted disease clinics. The Gonozyme method was compared directly with culture.
MATERIALS AND METHODS
Patient population. This study was performed in two sexually transmitted disease clinics; one in Boston, Mass. (53 men and 155 women) and the other in Richmond, Calif. (64 men and 86 women). Urethral swabs or endocervical specimens were collected from patients attending these clinics and were transported to a separate laboratory for Gonozyme testing.
Specimen collection and cultural methods. Endocervical and urethral specimens were collected using cotton swabs. The swabs were inserted into the appropriate orifice, rotat-* Corresponding author. ed, removed, and then streaked directly onto TM medium and placed into a specimen storage solution for the Gonozyme test. For some assays performed in Boston, these swabs were also streaked onto a chocolate agar (CA) plate before insertion into the Gonozyme transport medium. Presumptive identification of N. gonorrhoeae was based on compatible colonial morphology, oxidase reaction, and demonstration of gram-negative diplococci and was confirmed by appropriate sugar utilization patterns.
Gonozyme procedure. The principles of this test are as follows. (i) The clinical specimen is added to a specially treated bead which adsorbs gonococci and gonococcal antigens. (ii) After being washed to remove unbound material, the bead is exposed to rabbit antigonococcal antibody. (iii) Unbound rabbit antibody is removed by washing, and goat antibody to rabbit immunoglobulin G, conjugated with horseradish peroxidase, is added. (iv) After a final washing, a peroxidase substrate is added, and a visible color reaction takes place if the specimen is positive. The intensity of the color reaction can be quantitated with a spectrophotometer and will reflect the amount of peroxidase bound to the bead. The amount of peroxidase bound depends on the amount of bound rabbit antibody, which in turn is a reflection of the adherent gonococcal antigen.
The Gonozyme reagents and equipment were supplied by Abbott Laboratories. Test kits included negative and positive controls that were included in each run. The swabs arrived in the laboratory immersed in the storage reagent (0.2 ml). Specimen dilution buffer (1.0 ml) was added for 5 min before processing. The specimens were then vortexed for 10 to 15 s, and excess fluid was removed from the swabs by rotating them against the side of the tubes. The specimens (0.2 ml) were then added to wells in plastic plates. One positive and three negative controls were processed in parallel. A Gonozyme-treated bead was submerged in each well. Sealing the wells with an adhesive-backed card, a 15-min incubation in a 37°C water bath, aspiration of well contents, and four (15 ml) washes in water with Abbott Laboratories Pentawasher II followed this and each of the two subsequent fluid additions: (i) rabbit antibody to N. Table 1 . The Gonozyme proved to be a relatively efficient method of detecting gonococcal antigen in this high-risk population. There was an overall culture-positive prevalence of 64.1% (75 of 117), and 70 of the 75 culture-positive men had positive Gonozyme tests, for a sensitivity of 93.3%. There were no false-positive reactions; thus, the specificity and predictive value of the positive Gonozyme reaction were 100%.
Cervical gonorrhea. There were differences in results obtained for women tested in Boston versus those tested in Richmond, and the separate results are presented in Table 2 . The sensitivity of the Gonozyme test appeared to be markedly affected by multiple use of the same swab. When swabs were used for two bacterial cultures (TM and CA) before being placed in the Gonozyme transport system, the sensitivity fell from the 70% (17 of 24; tings, cultures are not done regularly enough to yield optimal results and, owing to increased administrative and other costs, are relatively expensive. Thus, one might suggest that the Gonozyme assay could play a role in screening for gonococcal antigen in cervical secretions in relatively lowrisk populations. However, if the profile of sensitivity and specificity obtained in this study is projected into a relatively low-risk population, the projections do not suggest that it will be particularly useful. For example, in screening the high-risk women in both Boston and Richmond, the specificity of the test was ca. 97%. Projection of our "best case" analysis (Richmond data, with a sensitivity of 86.8% and a specificity of 97.9%) into a population with a 1% prevalence of gonorrhea yields the results presented in (3) . Although the numbers were small, their results were slightly better for women than for men.
In summary, the Gonozyme test appears to be capable of detecting gonococcal antigen in genital tract discharges of men and women. Its sensitivity, specificity, and predictive value are similar to those for the Gram stain in the case of symptomatic men with a high prevalence of gonococcal urethritis, and the test appears inadequate to replace culture for women. It is clear that some improvement in this test will be required before it can be recommended for routine screening.
